Latest / CareTalk: Healthcare. Unfiltered.
GLP-1s May Reduce Cancer Progression
Send us Fan Mail
GLP-1 drugs were designed for weight loss. Now they may be showing up in cancer research in a way nobody expected.
In this clip from our episode “The Business & Science Behind the GLP-1 Boom”, hosts David E. Williams and John Driscoll break down what the 2026 ASCO annual meeting revealed about GLP-1s and their potential to reduce cancer progression in lung, breast, colorectal, and liver cancer.
Listen to the full episode here
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.